384 studies found for:    Open Studies | "Shock"
Show Display Options
Rank Status Study
21 Recruiting Esmolol Effects on Heart and Inflammation in Septic Shock
Condition: Septic Shock
Intervention: Drug: Esmolol
22 Recruiting Esmolol Infusion for Patients With Septic Shock and Persistent Tachycardia
Condition: Septic Shock
Intervention: Drug: Esmolol
23 Recruiting Effect of Albumin Administration on Vasopressor Duration in Resolving Septic Shock
Condition: Shock, Septic
Interventions: Drug: 25% Albumin;   Drug: Placebo
24 Not yet recruiting Meropenem and Ciprofloxacin Dosing in Septic Shock
Condition: Septic Shock
Intervention:
25 Recruiting NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock
Condition: Shock, Septic
Interventions: Drug: Vasopressin;   Drug: Norepinephrine
26 Unknown  Severe Sepsis/Septic Shock on Admission to the General Surgical ICU
Conditions: Septic Shock;   Multiple Organ Failure;   Fatal Outcome
Intervention:
27 Recruiting Early Use of Norepinephrine in Septic Shock Resuscitation
Conditions: Septic Shock;   Severe Sepsis
Interventions: Drug: Early norepinephrine;   Drug: Placebo
28 Recruiting Early Goal Directed Sedation on Microcirculation in Septic Shock
Condition: Septic Shock
Intervention: Drug: Dexmedetomidine for sedation
29 Recruiting Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial
Condition: Cardiogenic Shock
Intervention: Device: HeartMate PHP
30 Not yet recruiting Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock
Conditions: Shock; Septic;   Critical Illness
Interventions: Other: Hemodynamical treatment TTP;   Other: Hemodynamical treatment MCG
31 Unknown  Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
Conditions: Severe Sepsis;   Septic Shock
Intervention:
32 Unknown  Terlipressin Administration in Septic Shock Refractory to Catecholamines
Condition: Septic Shock
Intervention: Drug: terlipressin
33 Recruiting Adsorbtion of Cytokines Early in Septic Shock: the ACESS Study
Conditions: Sepsis;   Septic Shock
Intervention: Device: CytoSorb 300ml device (3804606CE01)
34 Recruiting Hemofiltration in Burns: RESCUE (Randomized Controlled Evaluation of Hemofiltration in Adult Burn Patients With Septic Shock and Acute Renal Failure)
Conditions: Burns;   Hemofiltration;   Kidney Failure, Acute;   Shock, Septic
Interventions: Device: An FDA approved continuous renal replacement device;   Other: Control Group
35 Not yet recruiting Ulinastatin Treatment in Adult Patients With Severe Sepsis and Septic Shock in China
Conditions: Severe Sepsis;   Septic Shock
Interventions: Drug: ulinastatin;   Drug: Placebo
36 Recruiting Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
Conditions: Severe Sepsis;   Septic Shock;   Bacteremia
Intervention:
37 Unknown  Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia
Conditions: Septic Shock;   Nonchemotherapy Drug-induced Neutropenia;   Neutropenia After Chemotherapy in Oncohematological Patients;   Neutropenia in Patients With Aplastic Anemia
Interventions: Genetic: Mesenchymal stromal cells;   Drug: Standard therapy of septic shock
38 Unknown  Renal Resistive Index and Cardiac Output Changes During Resuscitation Predict the Occurrence of Acute Kidney Injury in Septic Shock Patients
Conditions: Critically Ill;   Acute Kidney Injury;   Septic Shock
Intervention:
39 Recruiting Effect of Remote Ischemic Conditioning on Trauma Patients With Hemorrhagic Shock
Condition: Hemorrhagic Shock
Intervention: Device: Pneumatic tourniquet
40 Not yet recruiting PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock
Condition: Septic Shock
Interventions: Drug: MEROPENEM;   Drug: PIPERACILLIN-TAZOBACTAM;   Drug: CEFEPIME

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years